Inimmune Corp. (Missoula, MT) is a privately held biotechnology company focused on the discovery and development of innovative immunotherapeutics and vaccines. Inimmune is harnessing the human immune system to create safe and effective treatments for allergy, infectious disease, autoimmunity and cancer. Their laboratories and offices are housed in the Montana Technology Enterprise Center (MonTEC) in Missoula.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/11/20 | $22,000,000 | Series A |
Two Bear Capital | undisclosed |
